Quantcast

Latest AstraZeneca Stories

2014-01-29 08:30:15

SAN DIEGO, Jan. 29, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today announced that it has performed its first 3D Liver tissue delivery. The achievement marks the delivery of Organovo's 3D Liver tissue to a laboratory outside of the company to a key opinion leader (KOL) for experimentation, and marks the achievement of a milestone along the pathway to commercial...

2014-01-29 08:29:27

- Preclinical development completed for H7N9 vaccine candidates that addresses significant unmet medical need - BEIJING, Jan. 29, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration (CFDA) to commence human clinical trials for its vaccine against Avian influenza A(H7N9) virus. The CTA was officially accepted...

2014-01-29 00:20:55

SINGAPORE and ZURICH, January 29, 2014 /PRNewswire/ -- Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that their influenza vaccine (gH1-Qbeta) met its primary end point for immunogenicity (seroconversion based on haemaglutination inhibition titres according to FDA criteria) in the Phase 1 clinical trial in healthy Asian volunteers. The induced immune response showed good cross-reactivity to recent...

2014-01-27 16:24:34

DUBLIN, Ireland, January 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/7dmdjw/market_for_select) has announced the addition of the "2014 Report on Select Cardiovascular Drugs in the GCC Region" [http://www.researchandmarkets.com/research/7dmdjw/market_for_select ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The local governments are increasingly focusing on improving the health...

2014-01-23 04:21:26

LONDON and BOSTON, January 23, 2014 /PRNewswire/ -- Stabilised GPCR (StaR(R)) Proteins Delivered For All Nominated Targets Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, has successfully completed the research phase of its antibody drug discovery collaboration with MedImmune, the global biologics research and development arm of AstraZeneca. In achieving this milestone, Heptares has delivered StaR(R) proteins...

2014-01-21 23:27:11

“2014 Deep Research Report on Global and China Propofol Industry” and “2014 Deep Research Report on Global And China Nucleotide Industry” are the new research reports added to the online library of DeepResearchReports.com. Dallas, Texas (PRWEB) January 21, 2014 2014 Deep Research Report on Global And China Nucleotide Industry is a professional and in-depth study on the current state of the nucleotide industry in Global and China. The report provides a basic overview of the...

2014-01-20 12:23:08

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019 Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019 Summary GBI Research has released its latest report for the pharmaceuticals industry, "Type 2 Diabetes...

2014-01-08 00:21:46

BASEL, Switzerland, Jan. 8, 2014 /PRNewswire/ -- Syngenta announced today that Robert Berendes, Head Business Development, will be leaving the company at the end of the first quarter to become co-owner and partner of a-connect, the global consulting firm specializing in strategy implementation, growth projects and change management. Robert joined Syngenta in 2002 from McKinsey & Company where he was a partner, and became a member of the Syngenta Executive Committee in 2007. Mike...

2014-01-07 08:26:25

NEW YORK, January 7, 2014 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Amgen Inc. (NASDAQ: AMGN), Cigna Corporation (NYSE: CI), AstraZeneca plc (NYSE: AZN), CareFusion Corporation (NYSE: CFN), and WellCare Health Plans, Inc. (NYSE: WCG). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related